Call Us

    Cognitive FX vs. SAINT® TMS: What's the Difference?

    Written by Neuro Wellness TMS Centers of AmericaMedically reviewed by Daniel Pietras, MDPublished November 3, 2026Last medically reviewed November 3, 2026Last updated November 3, 2026

    No, Cognitive FX's 5-day program is not SAINT®. Cognitive FX, a clinic in Provo, Utah, describes its $9,900 program as "our own protocol, delivered off-label" and says "our protocol has not been tested in the SAINT clinical trials." SAINT® is the FDA-cleared Magnus system, and Neuro Wellness TMS Centers of America is Florida's verified SAINT® provider. If you are in crisis, call or text 988.

    Key takeaways

    • Cognitive FX describes its 5-day TMS as "our own protocol, delivered off-label."
    • Cognitive FX states: "our protocol has not been tested in the SAINT clinical trials."
    • Cognitive FX uses its own fMRI targeting rather than Magnus Medical's FDA-cleared targeting system.
    • SAINT® is FDA-cleared (510(k) K220177) for adults 22+ with major depressive disorder.
    • Medicare has established a hospital outpatient payment rate for SAINT® ($19,703, CMS July 2025); Cognitive FX notes insurance is not billed.
    • Neuro Wellness in Coral Springs, Florida is a verified SAINT® provider listed by Magnus Medical.

    Quick answer

    No, Cognitive FX's 5-day program is not SAINT®. Cognitive FX, a clinic in Provo, Utah, describes its $9,900 program as "our own protocol, delivered off-label" and says "our protocol has not been tested in the SAINT clinical trials." SAINT® is the FDA-cleared Magnus system, and Neuro Wellness TMS Centers of America is Florida's verified SAINT® provider.

    Side by side

    SAINT® at Neuro WellnessCognitive FX accelerated fMRI-TMS (as published by Cognitive FX)
    What it isSAINT®, FDA-cleared (510(k) K220177, Sept 2022)"our own protocol, delivered off-label" [1]
    TargetingFDA-cleared SAINT® targeting software"rather than using Magnus Medical's proprietary targeting system, Cognitive FX uses its own fMRI-based method" [1]
    Trial evidence78.6% remission in the 2022 randomized controlled trial (Cole et al., Am J Psychiatry 2022;179:132–141)"our protocol has not been tested in the SAINT clinical trials" [1]
    AgesAdults 22+"adults and teens (14 and up)"; "treating teens, are off-label" [2]
    InsuranceMedicare payment rate ($19,703 hospital outpatient, CMS, July 2025); commercial plans may approve via prior authorization"Insurance: Not billed" [2]
    PriceFrom $25,000 for the full 5-day SAINT® course"$9,900 for the week, including the fMRI scan, targeting, TMS, CBT, physical therapy, massage, photobiomodulation and follow-up. Travel and lodging are extra." [2]
    Verified on Magnus Medical's provider locatorYes (Florida)No

    Why the prices can't be compared

    $9,900 and $25,000 are prices for two different treatments. Cognitive FX's price buys its own off-label protocol plus extras like massage and physical therapy. SAINT's price buys the FDA-cleared system and the protocol that produced the trial results. A lower price for a different treatment is not a discount on SAINT®.

    Does SAINT's 79% remission rate apply to Cognitive FX?

    No. Those results come from SAINT® trial patients. Cognitive FX says its protocol was not tested in those trials.

    Cognitive FX cost vs SAINT® cost

    Cognitive FX lists $9,900 for its 5-day program, with travel and lodging extra, and states "Insurance: Not billed" [2]. SAINT® at Neuro Wellness starts at $25,000 for the full 5-day course, and Medicare has a hospital outpatient payment rate for SAINT® of $19,703 (CMS, July 2025). The two prices buy two different treatments: Cognitive FX's price buys its own off-label protocol plus extras like massage and physical therapy, while SAINT®'s price buys the FDA-cleared system and the protocol that produced the trial results. A lower price for a different treatment is not a discount on SAINT®.

    Cognitive FX fMRI-guided TMS vs SAINT® fMRI targeting

    Cognitive FX states it uses its own fMRI-based method "rather than using Magnus Medical's proprietary targeting system" [1]. SAINT® uses FDA-cleared SAINT® targeting software that personalizes the target from your fMRI scan (510(k) K220177). Using an fMRI scan alone is not what makes a treatment SAINT® — the FDA-cleared targeting software and the protocol tested in the SAINT trials are.

    Is Cognitive FX TMS FDA-cleared?

    TMS devices are FDA-cleared, but Cognitive FX describes its 5-day program as "our own protocol, delivered off-label" [1] and states that "treating teens" is off-label [2]. SAINT® is the FDA-cleared system (510(k) K220177, September 2022) for personalized fMRI-targeted accelerated TMS, cleared for adults 22+ with major depressive disorder. An off-label schedule is not the same as an FDA-cleared treatment.

    Does Cognitive FX take insurance?

    No. Cognitive FX states "Insurance: Not billed" [2]. SAINT® has a Medicare hospital outpatient payment rate ($19,703, CMS, July 2025), and commercial plans may approve it via prior authorization. We verify your insurance benefits for free before you commit.

    Cognitive FX one-day TMS (ONE-D) vs SAINT®

    SAINT® is a 5-day, FDA-cleared protocol (510(k) K220177). Compressing the course into a single day is an off-label schedule, not SAINT®. Cognitive FX describes its accelerated 5-day schedule as "our own protocol, delivered off-label" [1]; any one-day (ONE-D) version is a different, off-label protocol, not a faster SAINT®. SAINT® is cleared for adults 22+ as a 5-day course.

    SAINT by Magnus Medical
    Watch & Learn

    Understanding SAINT® TMS: How It Works & What to Expect

    SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. These videos explain how it works and how it differs from conventional TMS.

    SAINT® is an FDA-cleared, fMRI-guided form of TMS developed at Stanford. Most patients complete treatment in one week — not the six weeks standard TMS requires.

    Follow a real patient through the five-day SAINT® treatment week

    Is SAINT® TMS Right for You?

    Tried antidepressants without enough relief? SAINT® TMS is an FDA-cleared, fMRI-guided treatment for adults with major depressive disorder who have not improved enough with antidepressant medication.

    SAINT® uses a personalized brain target and delivers treatment over five consecutive days. It differs from standard TMS in its targeting approach, treatment schedule, and research background. In a small randomized trial, 11 of 14 people receiving active treatment reached remission at the four-week assessment, compared with 2 of 15 receiving sham treatment. Results vary, and a five-day treatment course does not guarantee remission in five days.

    How SAINT® Works and How It Differs From Conventional TMS

    SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. This video explains how it works, and how it differs from conventional TMS.

    Conventional TMS usually means about 30 visits over 6 to 9 weeks. SAINT is five visits over five days.

    What makes it different: SAINT is the only FDA-cleared depression treatment that uses an fMRI scan to personalize the stimulation target to your individual brain. A 45-minute scan maps your brain and identifies the specific circuit linked to depression. Treatment is then delivered as ten 10-minute sessions per day, with 50-minute breaks between them, across five consecutive days.

    In clinical trials, 79% of participants reached remission, with an average of 2.6 days to remission. SAINT is generally well tolerated; the most common side effects reported were mild headache and temporary scalp discomfort at the treatment site.

    SAINT® at Neuro Wellness TMS Centers of America

    Coral Springs, Florida
    Free benefits check · Self-pay options available
    Call or Text: 954-827-9793

    Sources: Cole et al., American Journal of Psychiatry 2020;177:716-726 and 2022;179(2):132-141. magnusmedical.com/depression-therapy. PubMed 34711062. FDA 510(k) K220177.

    Insurance coverage for SAINT is currently limited and varies by plan. Individual results may vary. This video is educational and is not medical advice. Talk to a qualified clinician about whether SAINT is appropriate for you. If you are in crisis, call or text 988.

    Frequently Asked Questions

    Does Cognitive FX offer SAINT®?

    No. Cognitive FX offers its own fMRI-guided accelerated TMS protocol, which it describes as off-label and not tested in the SAINT clinical trials. It is not listed on Magnus Medical's SAINT® provider locator.

    How much does Cognitive FX TMS cost compared to SAINT®?

    Cognitive FX lists $9,900 for its 5-day program, with travel and lodging extra, and says insurance is not billed. SAINT® at Neuro Wellness starts at $25,000 for the full course, and Medicare has a payment rate for SAINT®.

    Is Cognitive FX's fMRI-guided TMS FDA-cleared?

    TMS devices are FDA-cleared, but Cognitive FX states its accelerated 5-day schedule, and treating teens, are off-label. SAINT® is the only FDA-cleared system for personalized fMRI-targeted accelerated TMS.

    What is the Cognitive FX cost vs SAINT® cost?

    Cognitive FX lists $9,900 for its 5-day program, with travel and lodging extra, and says "Insurance: Not billed." SAINT® at Neuro Wellness starts at $25,000 for the full 5-day course, and Medicare has a hospital outpatient payment rate for SAINT® ($19,703, CMS, July 2025). The two prices buy two different treatments — a lower price for a different treatment is not a discount on SAINT®.

    How does Cognitive FX fMRI-guided TMS compare to SAINT® fMRI targeting?

    Cognitive FX states it uses its own fMRI-based method "rather than using Magnus Medical's proprietary targeting system." SAINT® uses FDA-cleared SAINT® targeting software that personalizes the target from your fMRI scan (510(k) K220177). Using an fMRI scan alone is not what makes a treatment SAINT®.

    Is Cognitive FX TMS FDA-cleared?

    TMS devices are FDA-cleared, but Cognitive FX describes its 5-day program as "our own protocol, delivered off-label" and states that "treating teens" is off-label. SAINT® is the FDA-cleared system (510(k) K220177, September 2022) for personalized fMRI-targeted accelerated TMS in adults 22+ with major depressive disorder.

    Does Cognitive FX take insurance?

    No. Cognitive FX states "Insurance: Not billed." SAINT® has a Medicare hospital outpatient payment rate ($19,703, CMS, July 2025), and commercial plans may approve it via prior authorization. We verify your benefits for free before you commit.

    Cognitive FX one-day TMS (ONE-D) vs SAINT®?

    SAINT® is a 5-day, FDA-cleared protocol (510(k) K220177). Compressing the course into a single day is an off-label schedule, not SAINT®. Cognitive FX describes its accelerated 5-day schedule as "our own protocol, delivered off-label." SAINT® is cleared for adults 22+ as a 5-day course; any one-day (ONE-D) version is a different, off-label protocol, not a faster SAINT®.

    Important Safety Information

    Individual results vary. No outcome is guaranteed. Coverage varies by plan. SAINT® is contraindicated for people with non-removable magnetic-sensitive metal in or near the head, certain implanted devices, or increased intracranial pressure. Possible side effects include headache, fatigue, scalp discomfort and anxiety; TMS carries a small risk of seizure and, as with any depression treatment, a risk of worsening depression or suicidal thoughts. If you are in crisis, call or text 988.

    See if SAINT® is a fit, free

    Speak with our clinical team. A free consultation is the best way to get answers specific to your situation.

    Cognitive FX is a trademark of its owner. SAINT® is a registered trademark of Magnus Medical. Neuro Wellness TMS Centers of America is not affiliated with Cognitive FX. Individual results vary. No outcome is guaranteed. Coverage varies by plan. Quotes from Cognitive FX published materials were accessed November 2, 2026.